PYPD News and Press, PolyPid Ltd.

PETACH TIKVA, Israel, Feb. 25, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment effectiveness, right where care begins, today a...

2026-02-11 15:25:17 ET More on PolyPid PolyPid Ltd. (PYPD) Q4 2025 Earnings Call Transcript PolyPid Ltd. (PYPD) Discusses the Science and Business Case for D-PLEX100 in Tackling Surgical Site Infections Transcript Seeking Alpha’s Quant Rating on PolyPid ...

2026-02-11 15:24:18 ET PolyPid Ltd. (PYPD) Q4 2025 Earnings Call February 11, 2026 8:30 AM EST Company Participants Dikla Akselbrad - CEO & Director Ori Warshavsky - Chief Operating Officer - US Jonny Missulawin - Chief Financial Officer ... Read the ...

2026-02-11 13:49:53 ET Image source: The Motley Fool. Feb. 11, 2026 at 8:30 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-02-11 07:37:13 ET More on PolyPid PolyPid Ltd. (PYPD) Discusses the Science and Business Case for D-PLEX100 in Tackling Surgical Site Infections Transcript Seeking Alpha’s Quant Rating on PolyPid Historical earnings data for PolyPid Financial info...

The Company is in Advanced Stage s of Commercial U.S. Partner ship Discussions for D-PLEX₁₀₀ Positive FDA Pre-NDA Feedback Supports Rolling NDA Review ; Submission Expected to Begin by the E nd of the First Quarter of 2026 Conferenc...

Sun Life Financial Inc. (SLF) is expected to report $1.35 for Q4 2025 Copa Holdings S.A. Class A (CPA) is expected to report $4.4 for Q4 2025 Nabors Industries Ltd. (NBR) is expected to report $-2.93 for Q4 2025 Intercorp Financial Services Inc. (IFS) is expected to report $1.1 for Q4...

PolyPid Ltd. (PYPD) is expected to report $-0.34 for Q4 2025

PETACH TIKVA, Israel, Jan. 28, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its fourth quarter 2025 financial results and operational highlights before the...

PETACH TIKVA, Israel, Dec. 16, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced the appointment of Brooke Story as Chairman of the Board of Directo...